SECLIDEMSTAT

Seclidemstat is an LSD1 inhibitor in clinical trials for sarcomas and hematologic cancers. It disrupts epigenetic regulation of tumor growth. Side effects include cytopenias, nausea, fatigue, elevated liver enzymes, and GI symptoms.

SKU: 4c1895f16a7d Category: Tag:

Product Description


Mechanism of Action

SECLIDEMSTAT (ID 27428) displays a multidimensional biochemical activity profile integrating modulation of enzymatic pathways, receptor‑mediated signalling, mitochondrial bioenergetics, oxidative‑stress homeostasis, ion‑channel dynamics, membrane structural behaviour and transcription‑factor regulation. Structural modelling suggests interactions with catalytic residues, allosteric microdomains, transmembrane helices, signalling cofactors and cytoskeletal complexes. These interactions enable influence over phosphorylation cascades, second‑messenger flux (Ca²⁺, IP₃, DAG, cAMP), ROS balance, ATP turnover, membrane‑potential stability and organelle stress‑response thresholds.

Benefits and Applications

  • Receptor–ligand affinity analysis and docking studies
  • Enzyme‑kinetic profiling and catalytic‑flux pathway mapping
  • Mitochondrial‑function modelling and ATP/ROS system evaluation
  • Transcriptomic, metabolomic, proteomic and phosphoproteomic profiling
  • Cytoskeletal‑architecture and membrane‑dynamics exploration
  • Apoptosis, autophagy, necroptosis and ferroptosis pathway modelling
  • SAR/QSAR modelling and compound‑optimisation workflows
  • Mechanistic pharmacodynamics and dose–response simulation

Side Effects and Risks

  • Oxidative‑stress imbalance and elevated ROS
  • Mitochondrial overload or respiratory‑chain suppression
  • Disruption of Ca²⁺/Na⁺/K⁺ ion‑homeostasis
  • Unintended receptor cross‑talk or inhibitory signal interference
  • Cytoskeletal destabilisation and membrane‑integrity reduction
  • Dose‑dependent cytotoxicity or programmed‑cell‑death activation
  • Transcriptional and epigenetic instability
  • Inflammatory‑cascade activation (NF‑κB, MAPK, JNK)

Datasheet


Molecular Formula

C20H23ClN4O4S

Molecular Weight

450.9 g/mol

CAS Number

1423715-37-0

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance.

Purity

Purity information is available upon request (COA).

Synonym

Seclidemstat; SP-2577; TYH386V3WJ; UNII-TYH386V3WJ; SECLIDEMSTAT [INN]

IUPAC/Chemical Name

N-[(E)-1-(5-chloro-2-hydroxyphenyl)ethylideneamino]-3-(4-methylpiperazin-1-yl)sulfonylbenzamide

InChl Key

MVSQDUZRRVBYLA-HYARGMPZSA-N

InChl Code

InChI=1S/C20H23ClN4O4S/c1-14(18-13-16(21)6-7-19(18)26)22-23-20(27)15-4-3-5-17(12-15)30(28,29)25-10-8-24(2)9-11-25/h3-7,12-13,26H,8-11H2,1-2H3,(H,23,27)/b22-14+

References

https://pubchem.ncbi.nlm.nih.gov/compound/135565033;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download